McCammant; Matthew S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for McCammant; Matthew S..The latest application filed is for "fused pyrimidine derivatives as a2a / a2b inhibitors".
- McCammant; Matthew S. - Newark DE
| Patent | Date |
|---|---|
| Fused pyrimidine derivatives as A2A / A2B inhibitors Grant 11,168,089 - Wang , et al. November 9, 2 | 2021-11-09 |
| Fused Pyrimidine Derivatives As A2a / A2b Inhibitors App 20210261555 - Wang; Xiaozhao ; et al. | 2021-08-26 |
| Tricyclic Heterocycles As Fgfr Inhibitors App 20210171535 - McCammant; Matthew S. ; et al. | 2021-06-10 |
| Imidazopyrimidines And Triazolopyrimidines As A2a / A2b Inhibitors App 20210139485 - Wang; Xiaozhao ; et al. | 2021-05-13 |
| Fused Pyrimidine Derivatives As A2a / A2b Inhibitors App 20190375752 - Wang; Xiaozhao ; et al. | 2019-12-12 |
| Imidazopyrimidines And Triazolopyrimidines As A2a / A2b Inhibitors App 20190292188 - Wang; Xiaozhao ; et al. | 2019-09-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 